225 related articles for article (PubMed ID: 37745233)
1. Multi-biological functions of intermedin in diseases.
Yang Z; Li H; Wu P; Li Q; Yu C; Wang D; Li W
Front Physiol; 2023; 14():1233073. PubMed ID: 37745233
[TBL] [Abstract][Full Text] [Related]
2. Structure-function analyses reveal a triple β-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design.
Roehrkasse AM; Booe JM; Lee SM; Warner ML; Pioszak AA
J Biol Chem; 2018 Oct; 293(41):15840-15854. PubMed ID: 30139742
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of intermedin on cardiovascular, pulmonary and renal diseases: comparison with adrenomedullin and CGRP.
Holmes D; Campbell M; Harbinson M; Bell D
Curr Protein Pept Sci; 2013 Jun; 14(4):294-329. PubMed ID: 23745696
[TBL] [Abstract][Full Text] [Related]
4. Involvement of vascular endothelial growth factor signaling in CLR/RAMP1 and CLR/RAMP2-mediated pro-angiogenic effect of intermedin on human vascular endothelial cells.
Albertin G; Sorato E; Oselladore B; Mascarin A; Tortorella C; Guidolin D
Int J Mol Med; 2010 Aug; 26(2):289-94. PubMed ID: 20596610
[TBL] [Abstract][Full Text] [Related]
5. Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes.
Roh J; Chang CL; Bhalla A; Klein C; Hsu SY
J Biol Chem; 2004 Feb; 279(8):7264-74. PubMed ID: 14615490
[TBL] [Abstract][Full Text] [Related]
6. Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin
Babin KM; Karim JA; Gordon PH; Lennon J; Dickson A; Pioszak AA
J Biol Chem; 2023 Jun; 299(6):104785. PubMed ID: 37146967
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of components of the cardiomyocyte adrenomedullin/intermedin receptor system following blood pressure reduction in nitric oxide-deficient hypertension.
Zhao Y; Bell D; Smith LR; Zhao L; Devine AB; McHenry EM; Nicholls DP; McDermott BJ
J Pharmacol Exp Ther; 2006 Mar; 316(3):1269-81. PubMed ID: 16326922
[TBL] [Abstract][Full Text] [Related]
8. Intermedin (adrenomedullin-2): a novel counter-regulatory peptide in the cardiovascular and renal systems.
Bell D; McDermott BJ
Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S247-62. PubMed ID: 17965749
[TBL] [Abstract][Full Text] [Related]
9. Comparisons between the effects of calcitonin receptor-stimulating peptide and intermedin and other peptides in the calcitonin family on bone resorption and osteoclastogenesis.
Granholm S; Henning P; Lerner UH
J Cell Biochem; 2011 Nov; 112(11):3300-12. PubMed ID: 21748786
[TBL] [Abstract][Full Text] [Related]
10. Intermedin enhances sympathetic outflow via receptor-mediated cAMP/PKA signaling pathway in nucleus tractus solitarii of rats.
Li P; Sun HJ; Han Y; Wang JJ; Zhang F; Tang CS; Zhou YB
Peptides; 2013 Sep; 47():1-6. PubMed ID: 23816795
[TBL] [Abstract][Full Text] [Related]
11. Intermedin alleviates the inflammatory response and stabilizes the endothelial barrier in LPS-induced ARDS through the PI3K/Akt/eNOS signaling pathway.
Fan S; Qi D; Yu Q; Tang X; Wen X; Wang D; Deng X
Int Immunopharmacol; 2020 Nov; 88():106951. PubMed ID: 32892076
[TBL] [Abstract][Full Text] [Related]
12. Adrenomedullin - Current perspective on a peptide hormone with significant therapeutic potential.
Fischer JP; Els-Heindl S; Beck-Sickinger AG
Peptides; 2020 Sep; 131():170347. PubMed ID: 32569606
[TBL] [Abstract][Full Text] [Related]
13. Intermedin/adrenomedullin2: an autocrine/paracrine factor in vascular homeostasis and disease.
Ni X; Zhang J; Tang C; Qi Y
Sci China Life Sci; 2014 Aug; 57(8):781-9. PubMed ID: 25104450
[TBL] [Abstract][Full Text] [Related]
14. Adrenomedullin 2/intermedin in the hypothalamo-pituitary-adrenal axis.
Takahashi K; Morimoto R; Hirose T; Satoh F; Totsune K
J Mol Neurosci; 2011 Feb; 43(2):182-92. PubMed ID: 20596793
[TBL] [Abstract][Full Text] [Related]
15. Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25.
Hay DL; Garelja ML; Poyner DR; Walker CS
Br J Pharmacol; 2018 Jan; 175(1):3-17. PubMed ID: 29059473
[TBL] [Abstract][Full Text] [Related]
16. Localization of calcitonin receptor-like receptor (CLR) and receptor activity-modifying protein 1 (RAMP1) in human gastrointestinal tract.
Cottrell GS; Alemi F; Kirkland JG; Grady EF; Corvera CU; Bhargava A
Peptides; 2012 Jun; 35(2):202-11. PubMed ID: 22484227
[TBL] [Abstract][Full Text] [Related]
17. Intermedin functions as a pituitary paracrine factor regulating prolactin release.
Lin Chang C; Roh J; Park JI; Klein C; Cushman N; Haberberger RV; Hsu SY
Mol Endocrinol; 2005 Nov; 19(11):2824-38. PubMed ID: 16002435
[TBL] [Abstract][Full Text] [Related]
18. Intermedin in paraventricular nucleus attenuates sympathetic activity and blood pressure via nitric oxide in hypertensive rats.
Zhou YB; Sun HJ; Chen D; Liu TY; Han Y; Wang JJ; Tang CS; Kang YM; Zhu GQ
Hypertension; 2014 Feb; 63(2):330-7. PubMed ID: 24218431
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of intermedin/adrenomedullin2 on ischemia/reperfusion injury in isolated rat hearts.
Yang JH; Qi YF; Jia YX; Pan CS; Zhao J; Yang J; Chang JK; Tang CS
Peptides; 2005 Mar; 26(3):501-7. PubMed ID: 15652657
[TBL] [Abstract][Full Text] [Related]
20. Intermedin protects HUVECs from ischemia reperfusion injury via Wnt/β-catenin signaling pathway.
Wang Y; Wu Z; Tian J; Mi Y; Ren X; Kang J; Zhang W; Zhou X; Wang G; Li R
Ren Fail; 2019 Nov; 41(1):159-166. PubMed ID: 30931679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
